San Diego, CA, United States of America

Andrew Beernink

This inventor holds 1 USPTO granted patent. Top assignee: Saryna Biotechnologies LLC. Active years: 2010.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrew Beernink

Introduction

Andrew Beernink is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of fluidic systems, particularly through his innovative patent. His work focuses on enhancing the efficiency of sample analysis in various applications.

Latest Patents

Andrew Beernink holds a patent for "Direct mixing and injection for high throughput fluidic systems." This invention provides a system and method for mixing and injecting discrete sample mixtures into a flow cytometer or other sample analysis apparatus. The design includes a sample injection guide that couples a liquid handling apparatus with a sample analysis apparatus, facilitating the injection of discrete sample mixtures into the fluidic system of the apparatus. He has 1 patent to his name.

Career Highlights

Andrew is currently employed at Saryna Biotechnologies LLC, where he continues to develop innovative solutions in biotechnology. His expertise in fluidic systems has positioned him as a valuable asset to his team and the industry.

Collaborations

Throughout his career, Andrew has collaborated with notable professionals, including Alex Okun and Teresa A Bennett. These partnerships have contributed to the advancement of his projects and the overall success of his endeavors.

Conclusion

Andrew Beernink's contributions to the field of fluidic systems exemplify the impact of innovation in biotechnology. His patent and ongoing work at Saryna Biotechnologies LLC highlight his commitment to advancing technology in sample analysis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…